Neuronal Peroxisome Proliferator-Activated Receptor γ Signaling: Regulation by Mood-Stabilizer Valproate
- 25 April 2008
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Molecular Neuroscience
- Vol. 35 (2), 225-234
- https://doi.org/10.1007/s12031-008-9056-8
Abstract
Valproate (Depakote) remains an effective medication for the prevention and treatment of seizures in epilepsy and of mood symptoms in bipolar disorder. Both of these disorders are severe and debilitating, and both warrant further medication options as well as a better understanding of the side effects associated with their current treatments. Although a number of molecular and cellular processes have been found to be altered by valproate, the medication's therapeutic mechanism has not been fully elucidated. In this paper, peroxisome proliferator-activated receptor (PPAR) signaling was examined to determine valproate's effects on this transcriptional regulatory system in neuronal tissue. PPAR signaling has been found to affect a number of biochemical processes, including lipid metabolism, cellular differentiation, insulin sensitivity, and cell survival. When primary neuronal cultures were treated with valproate, a significant decrease in PPARgamma signaling was observed. This effect was demonstrated through a change in nuclear quantities of PPARgamma receptor and decreased DNA binding of the receptor. Valproate also caused gene expression changes and a change to the peroxisome biochemistry consistent with a decrease of PPARgamma signaling. These biochemical changes may have functional consequences for either valproate's therapeutic mechanism or for its neurological side effects and merit further investigation.Keywords
This publication has 65 references indexed in Scilit:
- Effects of Peroxisome Proliferator-Activated Receptors on Lipoprotein Metabolism and Glucose Control in Type 2 Diabetes MellitusThe American Journal of Cardiology, 2007
- Effects of rosiglitazone on global ischemia-induced hippocampal injury and expression of mitochondrial uncoupling protein 2Biochemical and Biophysical Research Communications, 2006
- The Anti-Apoptotic, Glucocorticoid Receptor Cochaperone Protein BAG-1 Is a Long-Term Target for the Actions of Mood StabilizersJournal of Neuroscience, 2005
- A Peroxisome Proliferator-Activated Receptor-γ Agonist Reduces Infarct Size in Transient but Not in Permanent IschemiaStroke, 2005
- The mood stabilizer valproic acid stimulates GABA neurogenesis from rat forebrain stem cellsJournal of Neurochemistry, 2004
- Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathwayExperimental Cell Research, 2004
- EpilepsyNew England Journal of Medicine, 2001
- The Mood‐Stabilizing Agents Lithium and Valproate RobustlIncrease the Levels of the Neuroprotective Protein bcl‐2 in the CNSJournal of Neurochemistry, 1999
- Effect of Valproate on Cerebral Metabolism and Blood Flow: An18F‐2‐Deoxyglusose and15O Water Positron Emission Tomography StudyEpilepsia, 1996
- Synergistic induction of acyl-CoA oxidase activity, an indicator of peroxisome proliferation, by arachidonic acid and retinoic acid in Morris hepatoma 7800C1 cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995